Clinical Trials on Pulmonary Nodules

Total 8586 results

Kazakhstan Academy of Preventive Medicine
Philip Morris International; Synergy Research Group Kazakhstan; HealthCity LLP

Completed

Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan

Chronic Obstructive Pulmonary Disease (COPD)

Kazakhstan
University of Ulster
KU Leuven; Belfast Health and Social Care Trust; Queen's University, Belfast; Western...

Completed

Physical Activity Versus Pulmonary Rehabilitation in COPD (LIVELY)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, United Kingdom, United States, Australia, Austria, Brazil, Hungary, New Zealand, Romania, Russian Federation
AstraZeneca

Completed

The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)

Chronic Obstructive Pulmonary Disease, COPD

France, Poland, South Africa, Spain, United States, Canada, United Kingdom
UPECLIN HC FM Botucatu Unesp
Faculdade de Medicina do ABC; IEP São Lucas - Instituto de Ensino e Pesquisa; Hemocentro São Lucas and other collaborators

Unknown

Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
University of Southern Denmark
The Ministry of Science, Technology and Innovation, Denmark; Region of Southern...

Unknown

Prognosis and Treatment of COPD in Primary Care-use of Biomarkers (PROTECCT-M)

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
Zhujiang Hospital
Guangzhou Institute of Respiratory Disease

Completed

Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

China
Beijing Chao Yang Hospital

Unknown

Evaluation of Reactive Oxygen Metabolites in the Value of COPD

COPD(Chronic Obstructive Pulmonary Disease)

China
Novartis Pharmaceuticals

Completed

QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (ILLUMINATE)

Chronic Obstructive Pulmonary Disease (COPD)

Spain, Germany, Estonia, Hungary, Belgium, Czech Republic, Norway, Korea, Republic of, Lithuania
Minneapolis Veterans Affairs Medical Center

Completed

Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
Novartis

Completed

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, Belgium, Spain, Turkey, Italy, Canada, Australia
GlaxoSmithKline

Completed

A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)

Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)

Germany
Novartis

Completed

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States, Spain, Turkey, France, Netherlands, Germany
University of Colorado, Denver
National Cancer Institute (NCI); University of Kentucky; University of Louisville and other collaborators

Not yet recruiting

Precision Lung Cancer Survivorship Care Intervention (KYLEADSII)

Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer, Lung | Cancer of the Lung | Pulmonary Neoplasm | Lung Cancers | Neoplasm, Pulmonary | Cancers, Lung | Cancer, Pulmonary | Cancers, Pulmonary | Pulmonary Cancers
University of Zurich

Active, not recruiting

HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)

Pulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Vascular Disorder

Switzerland
University of Zurich

Active, not recruiting

HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)

Pulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Vascular Disease

Switzerland
Papworth Hospital NHS Foundation Trust
Merck Sharp & Dohme LLC

Completed

Serum Bio-markers in Pulmonary Hypertension

Pulmonary Hypertension, Primary, 4

United Kingdom
Schön Klinik Berchtesgadener Land

Unknown

Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD

Chronic Obstructive Pulmonary Disease | Idiopathic Pulmonary Fibrosis

Germany
Taipei Medical University

Unknown

Effects of a Comprehensive Health Coaching Program in Advanced Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End Stage

Taiwan
Vanderbilt University Medical Center
Johns Hopkins University

Completed

A Mobile Health Intervention in Pulmonary Arterial Hypertension (mHealth)

Pulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Associated Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial Hypertension

United States
Epix Pharmaceuticals, Inc.

Completed

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States
Beth Israel Medical Center
Johnson & Johnson

Completed

Music Therapy in the Treatment of Chronic Obstructive Pulmonary Disease

Pulmonary Diseases

United States
University College, London
University of Cambridge; National Institute for Health Research, United Kingdom and other collaborators

Unknown

Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
University of Florida
United Therapeutics

Terminated

Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

Chronic Obstructive Pulmonary Disease | Pulmonary Arterial Hypertension

United States
National Taipei University of Nursing and Health...

Terminated

Bubble PEP Training Among Patient With Chronic Obstructive Pulmonary Disease in Pulmonary Function Effects

Chronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With Exacerbation

Taiwan
Cukurova University

Completed

Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation

Anesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease Mild

Turkey
Imperial College Healthcare NHS Trust
National Institute for Health Research, United Kingdom

Terminated

The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients

Chronic Obstructive Pulmonary Diseases

United Kingdom
Randall Debattista
University of Malta, Faculty of Health Sciences

Not yet recruiting

Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD (NMES)

Chronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
Hospital Clinic of Barcelona

Completed

Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD) (SIL-COPD-01)

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

Spain
Strados Labs, Inc.

Withdrawn

Utility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Pulmatrix Inc.

Completed

A Phase 1b Study of PUR1800 in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Mylan Inc.
Theravance Biopharma

Completed

A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chiesi Farmaceutici S.p.A.

Completed

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)

COPD (Chronic Obstructive Pulmonary Disease)

China, Korea, Republic of, Taiwan
Hannover Medical School
CAPNETZ Stiftung

Completed

Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD

Chronic Obstructive Pulmonary Disease (COPD)

Germany
University of Aarhus

Completed

Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease, COPD

Denmark
Barcelona Institute for Global Health
KU Leuven; University Medical Center Groningen; University of Athens; University... and other collaborators

Completed

Non-interventional Cross-over Study to Reduce Items of PROactive Tools Measuring Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands, Greece, Belgium, United Kingdom
Novartis Pharmaceuticals

Withdrawn

Efficacy of Indacaterol 150 µg Versus Formoterol

Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals

Withdrawn

Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control (INITIATE)

Chronic Obstructive Pulmonary Disease (COPD)
Memorial Hospital of Rhode Island
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Translating The GOLD COPD Guidelines Into Primary Care Practice (LungAge)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Norwegian University of Science and Technology

Completed

Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs

Chronic Obstructive Pulmonary Disease (COPD)

Norway
Novartis Pharmaceuticals

Completed

Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients (INHALATOR)

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
University of Pennsylvania

Terminated

A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chest Hospital, Ministry of Health and Welfare,...

Completed

Respiratory Rehabilitation Exercises in Older Adults With Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Taiwan
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (GLOW7)

Chronic Obstructive Pulmonary Disease (COPD)

China, Philippines, Korea, Republic of, India
AstraZeneca

Completed

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Romania, Ukraine, Denmark, Netherlands, Canada
Novartis Pharmaceuticals

Completed

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease (INTRUST1)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines

Clinical Trials on Pulmonary Nodules

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations